SFL – Filing of Annual Report 2023 on form 20-F
SFL Corporation Ltd. (NYSE: SFL) (“SFL” or the “Company”) announces that its annual report on Form 20-F for the financial […]
EHang Reports Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results
Quarterly Revenues Increased by 260.9% YoY, 97.8% QoQ, Fiscal Year Revenues Increased by 165.0% Maintained Stable and High Gross Margin […]
ResMed’s 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
36,000 people across 17 markets responded to the company’s fourth annual survey. 40% of respondents get no more than three […]
Cornish Metals Announces Change In Executive Management
VANCOUVER, British Columbia, March 15, 2024 (GLOBE NEWSWIRE) — Cornish Metals Inc. (AIM/TSX-V: CUSN) (“Cornish Metals” or the “Company”), announces […]
Vivoryon Therapeutics N.V. Announces Changes to Board Composition
Vivoryon Therapeutics N.V. Announces Changes to Board Composition Halle (Saale) / Munich, Germany, March 15, 2024 – Vivoryon Therapeutics N.V. (Euronext […]
ADC Therapeutics gibt Geschäftsergebnisse für das 4. Quartal und das Gesamtjahr 2023 sowie aktuelle Geschäftszahlen bekannt
ZYNLONTA®(Loncastuximab-Tesirin-Lpyl) Nettoumsatz von 16,6 Mio. US-Dollar im 4. Quartal 2023 und 69,1 Mio. US-Dollar für das Gesamtjahr 2023; Umsatzwachstum im […]
